Company intelligence / Profile preview
Fusen Pharmaceutical
Nanyang, Henan, Chinaen.fusenpharma.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Fusen Pharmaceutical has a broad commercial portfolio focused on traditional Chinese patent medicines and chemical generics. Its best-known product lines include Shuanghuanglian oral solutions/injections for colds/respiratory infections. The company recently received approval in China for acetylcysteine effervescent tablets to treat chronic respiratory diseases such as COPD and chronic bronchitis. No clinical-stage novel NCEs or biologics are reported.
- Therapeutic areas
- Metabolic DisordersPulmonologyHematologyCardiovascularInfectious Diseases
- Modalities
- Small moleculeBiologicTraditional Chinese medicineChemical generic drugs
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Fusen Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Fusen Pharmaceutical.